O	0	8	Managing
O	9	15	Cancer
O	16	20	Care
O	20	21	:
O	22	23	a
B-intervention	24	30	psycho
I-intervention	30	31	-
I-intervention	31	42	educational
O	43	55	intervention
O	56	58	to
O	59	66	improve
O	67	76	knowledge
O	77	79	of
O	80	84	care
O	85	92	options
O	93	96	and
O	97	103	breast
O	104	110	cancer
O	111	115	self
O	115	116	-
O	116	126	management
O	126	127	.

O	128	130	We
O	131	137	tested
O	138	141	the
O	142	153	feasibility
O	154	157	and
O	158	171	acceptability
O	172	174	of
O	175	176	a
O	177	183	psycho
O	183	184	-
O	184	195	educational
O	196	200	self
O	200	201	-
O	201	211	management
O	212	224	intervention
O	224	225	,
O	226	234	Managing
O	235	241	Cancer
O	242	246	Care
O	246	247	:
O	248	249	A
O	250	258	Personal
O	259	264	Guide
O	265	266	(
O	266	269	MCC
O	269	270	)
O	270	271	,
O	272	274	to
O	275	282	improve
O	283	292	knowledge
O	293	295	of
O	296	300	care
O	301	308	options
O	309	310	(
O	310	318	curative
O	318	319	,
O	320	330	palliative
O	330	331	,
O	332	335	and
O	336	343	hospice
O	344	348	care
O	348	349	)
O	350	355	among
O	356	357	a
O	358	363	range
O	364	366	of
O	367	373	breast
O	374	380	cancer
O	381	385	self
O	385	386	-
O	386	396	management
O	397	403	skills
O	403	404	.

O	405	407	We
O	408	417	conducted
O	418	419	a
O	420	423	one
O	423	424	-
O	424	429	group
O	429	430	,
O	431	434	pre
O	434	435	-
O	435	439	post
O	439	440	-
O	440	444	test
O	445	450	study
O	451	456	among
B-eligibility	457	462	women
I-eligibility	463	467	with
I-eligibility	468	471	non
I-eligibility	471	472	-
I-eligibility	472	482	metastatic
I-eligibility	483	489	breast
I-eligibility	490	496	cancer
O	497	498	(
O	498	499	n
O	500	501	=
B-total-participants	502	505	105
O	505	506	)
O	506	507	.

O	508	510	We
O	511	515	gave
O	516	528	participants
O	529	532	the
O	533	540	printed
O	540	541	,
O	542	546	self
O	546	547	-
O	547	553	guided
O	553	554	,
O	555	560	seven
O	560	561	-
O	561	567	module
O	568	580	intervention
O	581	590	following
O	591	601	enrollment
O	601	602	.

O	603	605	At
O	606	614	baseline
O	615	618	and
O	619	620	2
O	622	628	months
O	628	629	,
O	630	632	we
O	633	641	measured
B-outcome-Measure	642	651	knowledge
I-outcome-Measure	652	654	of
I-outcome-Measure	655	659	care
I-outcome-Measure	660	667	options
O	667	668	,
B-outcome-Measure	669	676	desired
I-outcome-Measure	677	680	and
I-outcome-Measure	681	687	actual
I-outcome-Measure	688	692	role
I-outcome-Measure	693	695	in
I-outcome-Measure	696	700	self
I-outcome-Measure	700	701	-
I-outcome-Measure	701	711	management
O	711	712	,
B-outcome-Measure	713	720	medical
I-outcome-Measure	721	734	communication
I-outcome-Measure	735	741	skills
O	741	742	,
B-outcome-Measure	743	753	experience
I-outcome-Measure	754	757	and
I-outcome-Measure	758	768	management
I-outcome-Measure	769	771	of
I-outcome-Measure	772	783	transitions
O	783	784	,
B-outcome-Measure	785	792	anxiety
O	792	793	,
B-outcome-Measure	794	804	depression
O	804	805	,
B-outcome-Measure	806	817	uncertainty
O	817	818	,
O	819	822	and
B-outcome-Measure	823	827	self
I-outcome-Measure	827	828	-
I-outcome-Measure	828	836	efficacy
O	836	837	.

O	838	840	We
O	841	850	conducted
O	851	861	interviews
O	862	864	to
O	865	871	obtain
O	872	878	module
O	879	886	ratings
O	887	890	and
O	891	902	qualitative
O	903	907	data
O	908	910	on
O	911	920	strengths
O	921	924	and
O	925	936	limitations
O	937	939	of
O	940	943	MCC
O	943	944	.

B-outcome	945	954	Knowledge
I-outcome	955	957	of
I-outcome	958	962	care
I-outcome	963	970	options
O	971	972	(
O	972	973	δ
O	974	975	=
O	976	977	0
O	977	978	.
O	978	980	40
O	981	982	(
O	982	983	1
O	983	984	.
O	984	986	11
O	986	987	)
O	987	988	,
O	989	990	p
O	991	992	=
O	993	994	0
O	994	995	.
O	995	999	0005
O	999	1000	)
O	1001	1004	and
B-outcome	1005	1012	desired
I-outcome	1013	1017	role
I-outcome	1018	1020	in
I-outcome	1021	1025	self
I-outcome	1025	1026	-
I-outcome	1026	1036	management
O	1037	1038	(
O	1038	1039	δ
O	1040	1041	=
O	1042	1043	-
O	1043	1044	0
O	1044	1045	.
O	1045	1047	28
O	1048	1049	(
O	1049	1050	1
O	1050	1051	.
O	1051	1053	08
O	1053	1054	)
O	1054	1055	,
O	1056	1057	p
O	1058	1059	=
O	1060	1061	0
O	1061	1062	.
O	1062	1066	0177
O	1066	1067	)
O	1068	1081	significantly
O	1082	1090	improved
O	1090	1091	.

O	1092	1096	Less
O	1097	1104	skilled
O	1105	1112	medical
O	1113	1126	communicators
O	1127	1140	significantly
B-outcome	1141	1149	improved
I-outcome	1150	1155	their
I-outcome	1156	1169	communication
O	1170	1171	(
O	1171	1172	δ
O	1173	1174	=
O	1175	1176	3
O	1176	1177	.
O	1177	1179	47
O	1179	1180	,
O	1181	1189	standard
O	1190	1199	deviation
O	1200	1201	=
O	1202	1203	6
O	1203	1204	.
O	1204	1206	58
O	1206	1207	,
O	1208	1209	p
O	1210	1211	=
O	1212	1213	0
O	1213	1214	.
O	1214	1218	0449
O	1218	1219	)
O	1219	1220	.

O	1221	1233	Multivariate
O	1234	1242	modeling
O	1243	1249	showed
O	1250	1254	that
O	1255	1262	changes
O	1263	1265	in
O	1266	1269	our
O	1270	1277	primary
O	1278	1286	outcomes
O	1287	1289	of
B-outcome	1290	1297	medical
I-outcome	1298	1311	communication
O	1312	1315	and
B-outcome	1316	1326	management
I-outcome	1327	1329	of
I-outcome	1330	1341	transitions
O	1342	1348	seemed
O	1349	1351	to
O	1352	1357	drive
O	1358	1366	positive
O	1367	1374	changes
O	1375	1377	in
O	1378	1381	our
O	1382	1391	secondary
O	1392	1400	outcomes
O	1401	1403	of
B-outcome	1404	1411	anxiety
O	1411	1412	,
B-outcome	1413	1423	depression
O	1423	1424	,
B-outcome	1425	1436	uncertainty
O	1436	1437	,
O	1438	1441	and
B-outcome	1442	1446	self
I-outcome	1446	1447	-
I-outcome	1447	1455	efficacy
O	1455	1456	.

O	1457	1469	Participants
O	1470	1476	highly
O	1477	1482	rated
O	1483	1486	MCC
O	1487	1490	and
O	1491	1499	reported
O	1500	1503	the
O	1504	1514	importance
O	1515	1517	of
O	1518	1531	understanding
O	1532	1536	care
O	1537	1544	options
O	1545	1552	despite
O	1553	1556	non
O	1556	1557	-
O	1557	1567	metastatic
O	1568	1575	disease
O	1575	1576	.

O	1577	1580	MCC
O	1581	1583	is
O	1584	1585	a
O	1586	1594	feasible
O	1595	1598	and
O	1599	1609	acceptable
O	1610	1615	means
O	1616	1618	of
O	1619	1628	improving
O	1629	1638	knowledge
O	1639	1641	of
O	1642	1646	care
O	1647	1654	options
O	1655	1658	and
O	1659	1664	other
O	1665	1672	aspects
O	1673	1675	of
O	1676	1682	breast
O	1683	1689	cancer
O	1690	1694	self
O	1694	1695	-
O	1695	1705	management
O	1705	1706	.

O	1707	1710	The
O	1711	1722	combination
O	1723	1725	of
O	1726	1733	modules
O	1734	1741	offered
O	1742	1744	in
O	1745	1748	MCC
O	1749	1756	appears
O	1757	1759	to
O	1760	1764	have
O	1765	1775	beneficial
O	1776	1787	interactive
O	1788	1795	effects
O	1795	1796	.

O	1797	1799	We
O	1800	1803	are
O	1804	1813	currently
O	1814	1821	testing
O	1822	1825	MCC
O	1826	1830	more
O	1831	1841	rigorously
O	1842	1844	in
O	1845	1846	a
O	1847	1857	randomized
O	1858	1868	controlled
O	1869	1874	trial
O	1875	1877	to
O	1878	1885	explore
O	1886	1895	mediating
O	1896	1899	and
O	1900	1910	moderating
O	1911	1924	relationships
O	1924	1925	.

O	1926	1935	Copyright
O	1936	1937	©
O	1938	1942	2015
O	1943	1947	John
O	1948	1953	Wiley
O	1954	1955	&
O	1956	1960	Sons
O	1960	1961	,
O	1962	1965	Ltd
O	1965	1966	.
